1. Home
  2. VSAT vs KRYS Comparison

VSAT vs KRYS Comparison

Compare VSAT & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ViaSat Inc.

VSAT

ViaSat Inc.

HOLD

Current Price

$84.94

Market Cap

9.6B

Sector

Technology

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$323.54

Market Cap

9.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSAT
KRYS
Founded
1986
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
9.3B
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
VSAT
KRYS
Price
$84.94
$323.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
11
Target Price
$59.80
$297.60
AVG Volume (30 Days)
2.2M
612.1K
Earning Date
05-19-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
94.42
128.00
EPS
N/A
3.62
Revenue
N/A
$389,130,000.00
Revenue This Year
$5.32
$38.74
Revenue Next Year
$3.57
$32.53
P/E Ratio
N/A
$89.99
Revenue Growth
N/A
33.94
52 Week Low
$24.95
$133.00
52 Week High
$93.03
$382.54

Technical Indicators

Market Signals
Indicator
VSAT
KRYS
Relative Strength Index (RSI) 53.23 43.03
Support Level $67.49 $318.87
Resistance Level $91.41 $377.89
Average True Range (ATR) 5.00 16.51
MACD 0.74 -3.95
Stochastic Oscillator 47.81 38.52

Price Performance

Historical Comparison
VSAT
KRYS

About VSAT ViaSat Inc.

Viasat Inc an world-wide provider of communications technologies and services, focused on making connectivity accessible, available and secure for current and future customers world-wide. The company has two reportable segments: communication services and defense and advanced technologies. It generates majority of revenue from communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers. It has presence in United States and Outside United States. The company generates majority of revenue from United States. Its products are Antennas, Terminals & radios, Modems, Semiconductors, Cybersecurity, Software & services, Home internet.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

Share on Social Networks: